John P. McCabe - 01 Mar 2022 Form 4 Insider Report for Oncorus, Inc.

Role
CFO and Treasurer
Signature
/s/ Brian J. Shea, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
02 Mar 2022, 15:40:29 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONCR Employee Stock Option (right to buy) Award $0 +90,000 $0.000000 90,000 01 Mar 2022 Common Stock 90,000 $2.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service through each such vesting date.